
Takes advantage of next-generation sequencing (NGS) technology to provide comprehensive, accurate screening of all 24 chromosomes for selection of euploid embryos.
Provides in vitro fertilization (IVF) data analysis in a single framework.
Provides a comprehensive and accurate assessment of all 24 chromosomes from an embryo biopsy for preimplantation genetic screening (PGS).
We offer a comprehensive karyomapping solution for preimplantation genetic diagnosis:
For whole-genome amplification.
For microarray analysis.
For scanning and imaging the HumanKaryomap BeadChip.
With karyomapping module for analysis.
Designed to improve the success of in vitro fertilization (IVF) by detecting subchromosomal imbalances in embryos of reciprocal translocation carriers.
A comprehensive, cost-effective solution for identifying causal variants implicated in inherited cardiac conditions (ICCs). It detects 174 genes related to 17 ICCs, including most cardiomyopathies and arrhythmias.
Targets 4800 genes, enabling labs to expand and streamline their sequencing portfolio.
Focuses on researching severe, recessive pediatric onset diseases.
An FDA-cleared in vitro diagnostic (IVD) next-generation sequencing test designed to detect 139 CFTR variants.
The first FDA-cleared in vitro diagnostic (IVD) next-generation sequencing test designed to sequence all protein coding regions and intron/exon boundaries of the CFTR gene, including two large deletions, two deep intronic mutations, and indels in homopolymeric regions such as the 2184delA deletion.
Designed by international consortia to provide the most comprehensive coverage of cytogenetically relevant genes for cancer studies.
A 12-sample BeadChip array that enables analysis of genetic and structural variation in the human genome, such as duplications, deletions, amplifications, copy-neutral LOH, and mosaicism.
Sequencing and cytogenomic array scanning on a single system, with a seamless transition between applications.